K-Ras G12C-IN-2
CAS No. 1629267-75-9
K-Ras G12C-IN-2( —— )
Catalog No. M12442 CAS No. 1629267-75-9
A novel and irreversible inhibitor of mutant K-ras G12C.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 662 | Get Quote |
|
| 50MG | 2142 | Get Quote |
|
| 100MG | 2790 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameK-Ras G12C-IN-2
-
NoteResearch use only, not for human use.
-
Brief DescriptionA novel and irreversible inhibitor of mutant K-ras G12C.
-
DescriptionA novel and irreversible inhibitor of mutant K-ras G12C.
-
In VitroK-Ras G12C-IN-2 is a covalent kras g12c inhibitor extracted from patent WO2014152588A1, compound V-35.
-
In Vivo——
-
Synonyms——
-
PathwayMAPK/ERK Signaling
-
TargetRas
-
RecptorRas
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number1629267-75-9
-
Formula Weight418.9171
-
Molecular FormulaC21H27ClN4O3
-
Purity>98% (HPLC)
-
SolubilityDMSO: ≥ 22 mg/mL
-
SMILESC=CC(=O)N1CC(C1)N2CCN(CC2)C(=O)CNC3=C(C=C(C(=C3)C4CC4)Cl)O
-
Chemical Name2-Propen-1-one, 1-[3-[4-[2-[(4-chloro-5-cyclopropyl-2-hydroxyphenyl)amino]acetyl]-1-piperazinyl]-1-azetidinyl]-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. From PCT Int. Appl. (2014), WO 2014152588 A1 20140925.
molnova catalog
related products
-
1-AM
A potent, selective, covalent KRAS G12C inhibitor that selectively inhibit KRAS G12C-dependent signaling and cancer cell growth at sub-micromolar concentrations.
-
MRTX1133
MRTX1133 is a potent, selective, noncovalent KRASG12D inhibitor. It has picomolar binding affinity, single-digit nanomolar activity in cellular assays. In addition, it has significant in vivo efficacy in tumor models harboring KRASG12D mutations.
-
(S)-BAY-293
(S)-BAY-293 (BAY293 S-enantiomer) is the S-enantiomer of BAY-293 as a negative control compound.
Cart
sales@molnova.com